Kodiak Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KOD and other ETFs, options, and stocks.

About KOD

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD.

CEO

Victor Perlroth

CEOVictor Perlroth

Employees

109

Employees109

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2009

Founded2009

Employees

109

Employees109

KOD Key Statistics

Market cap

895.86M

Market cap895.86M

Price-Earnings ratio

-3.72

Price-Earnings ratio-3.72

Dividend yield

—

Dividend yield—

Average volume

868.06K

Average volume868.06K

High today

$17.85

High today$17.85

Low today

$15.75

Low today$15.75

Open price

$15.86

Open price$15.86

Volume

1.24M

Volume1.24M

52 Week high

$19.39

52 Week high$19.39

52 Week low

$1.92

52 Week low$1.92

Analyst ratings

57%

of 7 ratings

Buy

28.6%

Hold

57.1%

Sell

14.3%

People also own

Based on the portfolios of people who own KOD. This list is generated using Robinhood data, and it’s not a recommendation.

Virgin Galactic Holdings